Clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer.

Sectors
Healthcare
Life Sciences
First Invested
2017
Public/PIPES
Company Status
IPO/Acquired
NASDAQ/TSX: TRIL
Acquired by Pfizer